US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ACONW

Aclarion (ACONW)

Aclarion Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACONW

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/02	20 : 01	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ACONW	Aclarion Inc
2024/11/28	06 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACONW	Aclarion Inc
2024/11/23	06 : 03	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ACONW	Aclarion Inc
2024/11/21	22 : 00	GlobeNewswire Inc.	Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash	NASDAQ:ACONW	Aclarion Inc
2024/11/15	03 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACONW	Aclarion Inc
2024/11/14	05 : 06	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ACONW	Aclarion Inc
2024/11/09	06 : 18	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ACONW	Aclarion Inc
2024/11/05	20 : 00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ACONW	Aclarion Inc
2024/11/05	20 : 00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ACONW	Aclarion Inc
2024/11/05	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACONW	Aclarion Inc
2024/11/04	20 : 15	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ACONW	Aclarion Inc
2024/10/26	06 : 05	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ACONW	Aclarion Inc
2024/10/25	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACONW	Aclarion Inc
2024/10/16	05 : 00	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ACONW	Aclarion Inc
2024/10/12	05 : 36	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:ACONW	Aclarion Inc
2024/10/12	05 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACONW	Aclarion Inc
2024/10/10	20 : 00	GlobeNewswire Inc.	Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit	NASDAQ:ACONW	Aclarion Inc
2024/10/02	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACONW	Aclarion Inc
2024/09/27	19 : 57	GlobeNewswire Inc.	Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes	NASDAQ:ACONW	Aclarion Inc
2024/09/25	05 : 58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACONW	Aclarion Inc
2024/09/25	05 : 54	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ACONW	Aclarion Inc
2024/09/24	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACONW	Aclarion Inc
2024/09/24	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACONW	Aclarion Inc
2024/09/20	06 : 02	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:ACONW	Aclarion Inc
2024/09/12	19 : 57	GlobeNewswire Inc.	Aclarion Provides Corporate Update on Nociscan AI Technology Milestones	NASDAQ:ACONW	Aclarion Inc
2024/09/10	19 : 57	GlobeNewswire Inc.	Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial	NASDAQ:ACONW	Aclarion Inc
2024/09/05	19 : 57	GlobeNewswire Inc.	Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market	NASDAQ:ACONW	Aclarion Inc
2024/08/29	19 : 57	GlobeNewswire Inc.	Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey	NASDAQ:ACONW	Aclarion Inc
2024/08/21	20 : 57	GlobeNewswire Inc.	Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans	NASDAQ:ACONW	Aclarion Inc
2024/08/15	22 : 48	GlobeNewswire Inc.	Aclarion to Present at August 20th Virtual Investor Summit Microcap Event	NASDAQ:ACONW	Aclarion Inc

Showing the most relevant articles for your search:NASDAQ:ACONW

1 2 3 次へ >>

Financial Select Sector

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約